Oncology Central

Clonal diversity in glioblastoma: is it clinically relevant?


Glioblastoma (GBM), the most common primary brain cancer, is characterized by inter- and intra-patient genomic and histopathological diversity, arising from the complex dynamics that underpin its development. This diversity generates different patterns of clinical behavior whose common feature is the rapid emergence of treatment resistance.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.